|
| 35064522 | A Medicare Claims Analysis of Racial and Ethnic Disparities in the Access to Radiation Therapy Services. | J Racial Ethn Health Disparities | 2023 |
| 37963363 | Oncology Physician Workforce Diversity: Rationale, Trends, Barriers, and Solutions. | Cancer J | 2023 |
| 37560512 | Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer. | Phys Imaging Radiat Oncol | 2023 |
| 37652612 | In Reply to Shueng et al. | Int J Radiat Oncol Biol Phys | 2023 |
| 37823012 | Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. | Int J Part Ther | 2023 |
| 37345868 | In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer. | Acta Oncol | 2023 |
| 37179085 | Beyond Diversity Toward Inclusion, Belonging, and Safety. | Int J Radiat Oncol Biol Phys | 2023 |
| 37179078 | Perspectives on Diversity and Inclusion in Radiation Oncology: A Decade Later. | Int J Radiat Oncol Biol Phys | 2023 |
| 37444592 | Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy (IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma. | Cancers (Basel) | 2023 |
| 36520457 | Declining Representation and Reporting of Racial and Ethnic Minority Patients in Prostate Cancer Clinical Trials Despite Persistent Health Disparities-Where Progress Confronts Limitations. | JAMA Oncol | 2023 |
| 36721484 | Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma. | Int J Part Ther | 2023 |
| 36549345 | Development of a United States Radiation Oncology Curricular Framework: A Stakeholder Delphi Consensus. | Int J Radiat Oncol Biol Phys | 2023 |
| 36513260 | Impact of a Virtual Introduction to Radiation Oncology Presentation on Stimulating Interest in the Specialty Among Diverse Medical Students at Multiple Institutions. | J Am Coll Radiol | 2023 |
| 36399692 | Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality. | JCO Oncol Pract | 2023 |
| 36736631 | Radiotherapy Deserts: The Impact of Race, Poverty, and the Rural-Urban Continuum on Density of Providers and the Use of Radiation Therapy in the US. | Int J Radiat Oncol Biol Phys | 2023 |
| 36669542 | Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion-An ASTRO SCAROP-ADROP-ARRO Collaboration. | Int J Radiat Oncol Biol Phys | 2023 |
| 36529183 | Radiation Oncology Resident Perspectives on Diversity, Equity, and Inclusion: An Association of Residents in Radiation Oncology Equity and Inclusion Subcommittee Inaugural Resident Survey. | Int J Radiat Oncol Biol Phys | 2023 |
| 36702316 | Pilot Study Exploring the Feasibility of Incorporating Radiation Oncology Into Pre-existing Early Pathway Programs for Diverse Premedical Students. | Int J Radiat Oncol Biol Phys | 2023 |
| 36179990 | External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 36368435 | Demographic Trends Among American Society for Radiation Oncology Clinical Practice Guideline Task Force Participants From 2010 to 2022. | Int J Radiat Oncol Biol Phys | 2023 |
| 36367998 | Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. | J Clin Oncol | 2023 |
| 36306980 | The Current State of Departmental Diversity, Equity, and Inclusion Efforts Within US Academic Radiation Oncology Departments. | Int J Radiat Oncol Biol Phys | 2023 |
| 36316967 | The impact of salvage radiotherapy initiation at PSA⿿⿤⿿0.5⿿ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. | Prostate | 2023 |
| 34670241 | Establishing a Deaf and American Sign Language Inclusive Residency Program. | Acad Med | 2022 |
| 35478055 | Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. | Med Oncol | 2022 |
| 35671436 | Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care. | Am Soc Clin Oncol Educ Book | 2022 |
| 35605175 | Adjuvant Radiation for Pathologically Node-Positive Prostate Cancer: Evidence When Early Salvage May Not Be Early Enough. | J Clin Oncol | 2022 |
| 35494548 | Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review. | Adv Radiat Oncol | 2022 |
| 35427541 | Evaluating the Generalizability and Reproducibility of Scientific Research. | Int J Radiat Oncol Biol Phys | 2022 |
| 35449577 | Evaluating Proton Dose and Associated Range Uncertainty Using Daily Cone-Beam CT. | Front Oncol | 2022 |
| 36721485 | Treatment Planning of Bulky Tumors Using Pencil Beam Scanning Proton GRID Therapy. | Int J Part Ther | 2022 |
| 36620560 | A liquid immunogenic fiducial eluter for image-guided radiotherapy. | Front Oncol | 2022 |
| 36174619 | Tempering optimism for MRI-guided focused ultrasound therapy. | Lancet Oncol | 2022 |
| 35963472 | ASTRO Supports Access to Evidence-Based Cancer Care for All Patients, Regardless of Pregnancy Status, and Protection for Physicians Recommending and Providing Evidence-Based Care. | Int J Radiat Oncol Biol Phys | 2022 |
| 35963470 | Restricted Access to Abortion, the Dobbs Ruling, and Radiation Oncology: Standing United Against Reproductive Injustice. | Int J Radiat Oncol Biol Phys | 2022 |
| 36237768 | Gender Differences Among Academic Radiation Oncology National Institutes of Health (NIH) Funding Recipients. | Cureus | 2022 |
| 36053178 | Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease. | J Natl Cancer Inst | 2022 |
| 36395806 | Ensuring That Health Inequities and Disparities Are Not Exacerbated in the Evolving Oligometastatic Treatment Paradigm. | Int J Radiat Oncol Biol Phys | 2022 |
| 35017009 | A Survey to Assess and Delineate Approaches to Medical Student Outreach to Promote Diversity at Academic Radiation Oncology Programs. | Int J Radiat Oncol Biol Phys | 2022 |
| 35014708 | Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be? | Prostate | 2022 |
| 35013522 | Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. | Prostate Cancer Prostatic Dis | 2022 |
| 34882189 | Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation and Medical Oncology Faculty Over 5 Decades. | JAMA Oncol | 2022 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 32536574 | Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer. | Eur Urol Oncol | 2021 |
| 35530185 | Long-term Clinical Outcomes in Favorable Risk Prostate Cancer Patients Receiving Proton Beam Therapy. | Int J Part Ther | 2021 |
| 36218661 | Confronting Anti-Asian Racism and Health Disparities in the Era of COVID-19. | JAMA Health Forum | 2021 |
| 33497251 | Navigating Native Hawaiian and Pacific Islander Cancer Disparities From a Cultural and Historical Perspective. | JCO Oncol Pract | 2021 |
| 34977427 | Demographics of ASTRO Student Members and Potential Implications for Future U.S. Radiation Oncology Workforce Diversity. | Adv Radiat Oncol | 2021 |
| 34932087 | Healing and Health Equity for Asian American, Native Hawaiian, and Pacific Islander Populations. | JAMA | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |